Mind how you go: The current strategies for the development of therapies for Alzheimer's
disease are very diverse. Particular attention is given to the search for inhibitors (see picture …

Proteins are essential elements for life. They are building blocks of all organisms and the
operators of cellular functions. Humans produce a repertoire of at least 30,000 different …

The phylogenetically ancient, pentraxin family of plasma proteins, comprises C-reactive
protein (CRP) and serum amyloid P component (SAP) in humans and the homologous …

Alzheimer's disease is a neurodegenerative disorder characterized by neuronal loss, β‐
amyloid (Aβ) plaques, and neurofibrillary tangles. Complement protein C1q has been found …

The mechanisms underlying neurodegenerative sequelae of traumatic brain injury (TBI) are
poorly understood. The normal plasma protein, serum amyloid P component (SAP), which is …

The mechanisms responsible for neuronal death causing cognitive loss in Alzheimer's
disease (AD) and many other dementias are not known. Serum amyloid P component (SAP) …

New therapeutic approaches in Alzheimer's disease are urgently needed. The normal
plasma protein, serum amyloid P component (SAP), is always present in cerebrospinal fluid …

Serum amyloid P component (SAP) is a universal constituent of human amyloid deposits,
which has been implicated in Alzheimer's disease and major depressive disorder (MDD) …

Rolandic epilepsy is one of the most common epileptic syndromes in childhood. We used
TMT‐based proteomics and bioinformatics analysis to identify the differentially expressed …

Biomarkers of Alzheimer's disease (AD) progression are needed to support the development
of urgently needed disease modifying drugs. We employed a SOMAscan assay for …